DFLIW suppliers relationship map

Dragonfly Energy (DFLIW) — supplier map and commercial posture for investors

Dragonfly Energy sells LiFePO4 battery systems and battery management solutions to OEMs, retail channels and commercial integrators, monetizing through product sales and recurring OEM supply agreements while intermittently accessing public capital markets to fund growth. The company builds a vertically coordinated supply chain — sourcing cells and BMS components offshore and assembling finished packs in North America — and converts that supply position into revenue via exclusive OEM contracts and direct-to-consumer channels.

For a concise supplier-risk read on Dragonfly Energy, see more at https://nullexposure.com/.

The investment thesis in one paragraph

Dragonfly’s value proposition for operators and investors rests on being a branded LiFePO4 battery supplier with exclusive OEM arrangements (key account sales), concentrated upstream sourcing, and a product-led route to recurring revenue. Financially the firm generates revenue through hardware sales and OEM supply contracts while relying on capital markets and investment-banking relationships to refresh working capital and fund expansion. Given negative EBITDA and material supplier concentration, the risk/return profile is driven by execution on supply continuity and OEM ramp economics.

What the relationship list tells you — every counterparty covered

Below I walk through every counterparty flagged in public documents and press coverage. Each item is a concise, plain-English summary with the cited source context.

Keystone — Dragonfly signed a long-term Manufacturing Supply Agreement dated November 19, 2021 under which Dragonfly is the exclusive supplier to Keystone for certain future LFP battery requirements, anchoring a strategic OEM relationship. Source: Dragonfly’s FY2024 10‑K filing (Supply Agreement language) (FY2024).
Roth Capital Partners — Roth acted as a co‑manager on a public equity offering described in company press materials, indicating an active capital markets engagement to raise cash in FY2025. Source: Futunn news post on Dragonfly’s priced public offering (March 9, 2026; FY2025).
Canaccord Genuity / CF / CCORF — Canaccord Genuity is identified repeatedly as the sole bookrunner for Dragonfly’s offering; variants in reporting list Canaccord as “CF” or “CCORF” depending on the news feed. This illustrates a single lead underwriter role on the financing and a concentration of advisory relationships. Source: Futunn announcement of the $55.4 million offering and StockTitan SEC filing page referencing the same (March 2026; FY2025).
AdvisIRy Partners — AdvisIRy Partners is named as Dragonfly’s investor relations advisor and contact for IR communications in the public offering materials, signaling outsourced IR services for market communications. Source: Futunn press release listing investor relations contact information (FY2025).
Wakespeed — Wakespeed technology is cited in third‑party coverage as the charge control tech installed alongside Battle Born LiFePO4 batteries in a sleeper‑cab application; Dragonfly’s coverage of such integrated systems demonstrates channel partnerships and product integration in transportation use cases. Source: Futunn news coverage of award recognition mentioning Wakespeed and Battle Born batteries (FY2026).
CBIZ CPAs P.C. — CBIZ CPAs P.C. was ratified as Dragonfly’s independent auditor for 2025, indicating a recent auditor appointment for FY2025 financial statement audits. Source: StockTitan SEC filing summary referencing auditor ratification (FY2025).

Note: multiple entries in the records reference the same underwriting and advisory relationships under slightly different labels (Canaccord/CF/CCORF and Roth Capital duplicates); the summaries above consolidate those references while preserving the original source context.

Key operational constraints and what they imply for investors

Dragonfly’s public disclosures produce a consistent signal set about how the company operates and where execution risk concentrates.

Concentrated upstream sourcing in APAC (China). Dragonfly sources LFP cells from two carefully selected manufacturers in China and uses a single China‑based supplier for its proprietary battery management system. This gives the company scale and cost control but creates geopolitical and operational concentration risk. Source: company disclosures in FY2024–FY2025 filings.
Supplier criticality and limited redundancy. Management states that disruption of key suppliers would materially affect operations, framing these suppliers as critical to manufacturing continuity and revenue delivery. Investors must price continuity risk into valuations. Source: company risk disclosures (FY2024).
Mixed contracting posture — long relationships but limited long‑term supplier contracts at scale. Company statements show a dual posture: Dragonfly relies on long‑term supplier relationships and has specific long-term supply agreements that include minimum purchase commitments, yet it also reports a lack of significant long-term contracts across the broader supplier base. That duality results in selective locked-in OEM deals (e.g., Keystone) alongside generally flexible supplier arrangements, which increases commercial agility but also raises counterparty and supply certainty questions. Source: FY2024–FY2025 filing excerpts describing supply relationships and contract terms.
Manufacturing role and outsourced logistics. The company identifies suppliers as manufacturers of critical cell and BMS components and states that it outsources transport and delivery logistics, which reduces fixed capital but adds dependency on third-party service providers for fulfillment. Source: company disclosures.
Mature, active relationships with limited supplier count. Multiple filing excerpts describe the supplier base as developed, mature, and active, reflecting prioritized long relationships with a small set of vendors rather than broad supplier diversification. Source: FY2024–FY2025 disclosures.

What this means for commercial counterparties and operators

Revenue dependency on OEM wins and supply continuity. Exclusive OEM arrangements such as the Keystone agreement are revenue anchors; maintain strong contractual protections and ensure supply redundancy to protect margins. Keystone is a strategic sink for capacity, and any underperformance or supply hiccup will immediately hit reported sales.
Financial sensitivity to capital markets. Dragonfly’s recent public offering underwritten by Canaccord and co‑managed by Roth shows the firm relies on equity capital when operating cash flow is insufficient; investors should watch underwriting relationships and future financing cadence as a liquidity signal. Source: Futunn press release on the March 2026 offering (FY2025).
Audit and governance signal. The CBIZ appointment is a governance update investors should rationalize in diligence on financial reporting quality and auditor continuity. Source: StockTitan SEC filing page (FY2025).

Bottom line and recommended investor actions

Dragonfly offers a classic supplier‑concentrated, product-led small-cap growth risk profile: meaningful OEM contracts and a differentiated product set counterbalanced by supplier concentration in China and ongoing negative EBITDA. For investors and operators evaluating or negotiating counterparties:

Validate contract terms with Keystone‑class customers and confirm minimum purchase obligations and penalty protections.
Stress-test supply continuity plans for the two APAC cell suppliers and the single BMS manufacturer.
Monitor financing activity with Canaccord and Roth — new offerings will determine short‑term liquidity and dilution risk.

For a deeper counterparty risk map and ongoing monitoring resources, visit https://nullexposure.com/ for investor tools and supplier-tracking intelligence.

Key takeaway: Dragonfly’s commercial upside depends on scaling exclusive OEM relationships while neutralizing concentrated supplier risk; capital markets support has been active but execution on supply resilience is the gating item for valuation realization.